Sudden unexplained death in infants and children: The role of undiagnosed inherited cardiac conditions

Europace

Volumn 16, Issue 12, 2014, Pages 1706-1713

  Wong, Leonie C H ^a   Behr, Elijah R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Inherited cardiac conditions; Molecular autopsy; Sudden arrhythmic death syndrome; Sudden infant death syndrome

Indexed keywords

AUTOPSY; BRUGADA SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONGENITAL HEART MALFORMATION; CORONARY ARTERY ANOMALY; FIRST DEGREE RELATIVE; GENETIC SCREENING; HEART DISEASE; HUMAN; LONG QT SYNDROME; MICROSCOPY; MYOCARDITIS; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; SCREENING; SUDDEN CARDIAC DEATH; SUDDEN INFANT DEATH SYNDROME; THREE DIMENSIONAL IMAGING; ARRHYTHMIAS, CARDIAC; CAUSE OF DEATH; COMORBIDITY; FEMALE; GENETICS; INCIDENCE; INFANT; MALE; MOLECULAR PATHOLOGY; MORTALITY; NEWBORN; PRESCHOOL CHILD; PROCEDURES; RISK ASSESSMENT;

ARRHYTHMIAS, CARDIAC; BRUGADA SYNDROME; CAUSE OF DEATH; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; GENETIC TESTING; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PATHOLOGY, MOLECULAR; RISK ASSESSMENT;

EID: 84918818380     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu037     Document Type: Review

References (74)

1. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013;15: 1389-1406.
2. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol 1985;5:118B-121B.
3. Vaartjes I, Hendrix A, Hertogh EM, Grobbee DE, Doevendans PA, Mosterd A et al. Sudden death in persons younger than 40 years of age: incidence and causes. Eur J Cardiovasc Prev Rehabil 2009;16:592-596.
4. Papadakis M, Sharma S, Cox S, Sheppard MN, Panoulas VF, Behr ER. The magnitude of sudden cardiac death in the young: a death certificate-based reviewin England and Wales. Europace 2009;11:1353-1358.
5. Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL et al. Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J 2011; 32:983-990.
6. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust 2004;180:110-112.
7. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm 2005;2:1277-1282.
8. van der Werf C, van Langen IM,Wilde AA. Sudden death in the young: what do we know about it and how to prevent. Circ Arrhythm Electrophysiol 2010;3: 96-104.
9. Pilmer CM, Kirsh JA, Hildebrandt D, Krahn AD, Gow RM. Sudden cardiac death in children and adolescents between 1 and 19 years of age. Heart Rhythm 2013.
10. Winkel BG, Risgaard B, Sadjadieh G, Bundgaard H, Haunsø S, Tfelt-Hansen J. Sudden cardiac death in children (1-18 years): symptoms and causes of death in a nationwide setting. Eur Heart J 2013; doi:10.1093/eurheartj/eht509.
11. Unexplained deaths in infancy: England and Wales, 2009. Office for National Statistics, 2011. http://www.ons.gov.uk/ons/dcp171778-227450.pdf (6 August 2012
12. Mathews TJ, MacDormanMF. Infant Mortality Statistics from the 2008 Period Linked Birth/Infant Death Data Set. National Vital Statistics Reports; vol 60 no 5. Hyattsville, MD: National Center for Health Statistics, 2011. http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60-05.pdf (6 August 2012
13. Moon RY, Horne RSC, Hauck FR. Sudden infant death syndrome. Lancet 2007;370: 1578-1587.
14. Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M et al.; Association for European Cardiovascular Pathology. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 2008;452:11-18.
15. de Noronha SV, Behr ER, Papadakis M, Ohta-Ogo K, BanyaW,Wells J et al. The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths. Europace 2014;16:899-907.
16. Papadakis M, Raju H, Behr ER, De Noronha SV, Spath N, Kouloubinis A et al. Sudden cardiac death with autopsy findings of uncertain significance: potential for erroneous interpretation. Circ Arrhythm Electrophysiol 2013;6:588-596.
17. Bolliger SA, Thali MJ, Ross S, Buck U, Naether S, Vock P. Virtual autopsy using imaging: bridging radiologic and forensic sciences. A review of the virtopsy and similar projects. Eur Radiol 2008;18:273-282.
18. Crooijmans HJ, Ruder TD, Zech WD, Somaini S, Scheffler K, Thali MJ et al. Cardiovascular magnetization transfer ratio imaging compared with histology: a postmortem study. J Magn Reson Imaging 2013. .
19. Martinez RM, Ptacek W, Schweitzer W, Kronreif G, Fürst M, Thali MJ et al. CT-guided, minimally invasive, postmortem needle biopsy using the B-Rob II needlepositioning robot. J Forensic Sci 2013. .
20. Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A et al.; Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of firstdegree relatives in sudden arrhythmic death syndrome. Lancet 2003;362: 1457-1459.
21. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome EstebanMTet al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 2008;29:1670-1680.
22. Tan HL, HofmanN, van Langen IM, van derWalAC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005;112:207-213.
23. van derWerf C, Hofman N, Tan HL, van Dessel PF, Alders M, van derWal AC et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in the Netherlands. Heart Rhythm 2010;7:1383-1389.
24. Chugh SS, Senashova O,Watts A, Tran PT, Zhou Z, GongQet al. Postmortemmolecular screening in unexplained sudden death. J AmColl Cardiol 2004;43:1625-1629.
25. Tester DJ, Ackerman MJ. PostmortemlongQT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007;49:240-246.
26. Skinner JR, Crawford J, SmithW, Aitken A, HeavenD, EvansCAet al.; Cardiac Inherited Disease Group New Zealand. Prospective, population-based long QT molecular autopsy study of post-mortem negative sudden death in 1 to 40 year olds. Heart Rhythm 2011;8:412-419.
27. Winkel BG, Larsen MK, Berge KE, Leren TP, Nissen PH, Olesen MS et al. The prevalence ofmutations inKCNQ1,KCNH2 andSCN5Ain an unselected national cohort of young sudden unexplained death cases. J Cardiovasc Electrophysiol 2012;23: 1092-1098.
28. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the cardiac ryanodine receptor (RyR2) in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc 2004; 79:1380-1384.
29. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc 2012;87:524-539.
30. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007;115:361-367.
31. Otagiri T, Kijima K, Osawa M, Ishii K, Makita N, Matoba R et al. Cardiac ion channel gene mutations in sudden infant death syndrome. Pediatr Res 2008;64: 482-487.
32. Millat G, Kugener B, Chevalier P, Chahine M, Huang H, MalicierDet al. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol 2009;30:502-509.
33. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001;286:2264-2269.
34. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, StateMWet al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 2006;116:430-435.
35. Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 2007;4:161-166.
36. Tan B-H, Pundi KN, Van Norstrand DW, Valdivia CR, Tester DJ, Medeiros-Domingo A et al. Sudden infant death syndrome-Associated mutations in the sodium channel beta subunits. Heart Rhythm 2010;7:771-778.
37. Cheng J, VanNorstrandDW,Medeiros-Domingo A, Valdivia C, Tan BH, Ye B et al. Alpha1-syntrophinmutations Identified in sudden infant death syndrome cause an increase in late cardiac sodium current. Circ Arrhythm Electrophysiol 2009;2: 667-676.
38. Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR et al. A mechanism for sudden infant death syndrome (SIDS): Stress-induced leak via ryanodine receptors. Heart Rhythm 2007;4:733-739.
39. Van Norstrand DW, Valdivia CR, Tester DJ, Ueda K, London B, Makielski JC et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1-like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007;116:2253-2259.
40. Tester DJ, Tan B-H, Medeiros-Domingo A, Song C, Makielski JC, Ackerman MJ. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 KATP channel and sudden infant death syndrome. Circ Cardiovasc Genet 2011;4:510-515.
41. Van NorstrandDW, Asimaki A, Rubinos C, Dolmatova E, Srinivas M, Tester DJ et al. Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death. Circulation 2012;125:474-481.
42. Brion M, Allegue C, Santori M, Gil R, Blanco-Verea A, Haas C et al. Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Sci Int 2012;219: 278-281.
43. Filiano JJ, Kinney HC. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol Neonate 1994;65: 194-197.
44. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G et al. Prevalence of the congenital long-QT syndrome. Circulation 2009;120: 1761-1767.
45. Cerrone M, Napolitano C, Priori SG. Genetics of ion-channel disorders. Curr Opin Cardiol 2012;27:242-252.
46. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004;109: 1834-1841.
47. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti Ret al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-1714.
48. Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-BadialeMet al.Amolecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000;343:262-267.
49. Tester DJ, Ackerman MJ. Sudden infant death syndrome: how significant are the channelopathies? Cardiovasc Res 2005;67:388-396.
50. van derWerf C, Wilde AA. Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside. Heart 2013;99:497-504.
51. Roux-Buisson N, Cacheux M, Fourest-Lieuvin A, Fauconnier J, Brocard J, Denjoy I et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum Mol Genet 2012;21: 2759-2767.
52. Nyegaard M, Overgaard MT, Søndergaard MT, Vranas M, Behr ER, Hildebrandt LL et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet 2012;91:703-712.
53. AllouisM, Probst V, Jaafar P, Schott JJ, Le Marec H. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Am J Cardiol 2005;95:700-702.
54. Schwartz PJ. Cardiac sympathetic innervation and the sudden infant death syndrome: a possible pathogenic link. Am J Med 1976;60:167-172.
55. Antzelevich C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference. Circulation 2005; 111:659-670.
56. Veerakul G, Nademanee K. Brugada syndrome: two decades of progress. Circ J 2012; 76:2713-2722.
57. Raju H, Papadakis M, Govindan M, Bastiaenen R, Chandra N, O'Sullivan A et al. Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome. J Am Coll Cardiol 2011;57: 2340-2345.
58. Skinner JR, Chung S-K, Montgomery D, McCulley CH, Crawford J, French J et al. Near-miss SIDS due to Brugada syndrome. Arch Dis Child 2005;90:528-529.
59. Turillazzi E, La Rocca G, Anzalone R, CorraoS, Neri M, PomaraCet al. Heterozygous nonsense SCN5A mutation W822X explains a simultaneous sudden infant death syndrome. Virchows Arch 2008;453:209-216.
60. Hu D, Barajas-Martinez H, Medeiros-Domingo A, Crotti L, Veltmann C, Schimpf R et al. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. Heart Rhythm 2012;9: 760-769.
61. Kanter RJ, PfeifferR,HuD, Barajas-Martinez H, CarboniMP, Antzelevich C. Brugadalike syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. Circulation 2012;125:14-22.
62. Nof E, Cordeiro JM, Pérez GJ, Scornik FS, Calloe K, Love B et al. A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death. Circ Cardiovasc Genet 2010;3:199-206.
63. Burke A, Creighton W, Mont E, Li L, Hogan S, Kutys R et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation 2005;112: 798-802.
64. Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007; 115:368-376.
65. Maron BJ, Maron MS, Semsarian C. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. Heart Rhythm 2012;9:57-63.
66. Wong LC, Behr ER. Familial cardiological evaluation in sudden arrhythmic death syndrome: essential but challenging. Europace 2013;15:924-926.
67. McGorrian C, Constant O, Harper N, O'Donnell C, Codd M, Keelan E et al. Familybased cardiac screening in relatives of victims of sudden arrhythmic death syndrome. Europace 2013;15:1050-1058.
68. Tomaske M, Keller DI, Bauersfeld U. Sudden cardiac death: clinical evaluation of paediatric family members. Europace 2011;13:421-426.
69. Hofman N, Tan HL, AldersM, Kolder I, de Haij S, MannensMMet al. Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience. Circulation 2013;128:1513-1521.
70. HofmanN, Tan HL, Clur S-A, Alders M, van Langen IM, WildeAAM. Contribution of inherited heart disease to sudden cardiac death in childhood. Pediatrics 2007;120: e967-e973.
71. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H et al.; Heart Rhythm Society (HRS); European Heart Rhythm Association (EHRA). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace 2011;13:1077-1109.
72. Bai R, Napolitano C, Bloise R, Monteforte N, Priori SG. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol 2009;2:6-15.
73. Ingles J, Semsarian C. Cost-effectiveness of the 'Molecular Autopsy' in sudden unexplained death in the young. Heart Lung Circ 2012;21:S266.
74. Tester DJ, Medeiros-Domingo A, Haglund CM, Johnson JN, Ackerman MJ. Cost comparison between postmortem genetic testing and first degree relative clinical testing following autopsy negative sudden unexplained death. Circulation 2009;120: S566.